Tonix Pharmaceuticals: August PDUFA Date For Fibromyalgia Med A Risky Bet

Tonix Pharmaceuticals: August PDUFA Date For Fibromyalgia Med A Risky Bet #Tonix #Pharmaceuticals #August #PDUFA #Date…

JPMorgan cuts Rocket Pharmaceuticals stock rating to neutral

JPMorgan cuts Rocket Pharmaceuticals stock rating to neutral#JPMorgan #cuts #Rocket #Pharmaceuticals #stock #rating #neutral

ANI Pharmaceuticals Expands Stock Plans and Shares

ANI Pharmaceuticals Expands Stock Plans and Shares#ANI #Pharmaceuticals #Expands #Stock #Plans #Shares

Eton Pharmaceuticals Set To Dominate Orphan Drug Niche (NASDAQ:ETON)

This article was written by Follow My handle is the Michigan Value Investor, but everyone calls…

Regeneron Pharmaceuticals, Inc. (REGN) RBC Capital Markets Global Healthcare Conference (Transcript)

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) RBC Capital Markets Global Healthcare Conference May 20, 2025 11:00 AM ET…

Acadia Pharmaceuticals: Another Legal Win, ACP-101 Readout Preview

Acadia Pharmaceuticals: Another Legal Win, ACP-101 Readout Preview #Acadia #Pharmaceuticals #Legal #Win #ACP101 #Readout #Preview

WuXi Biologics Congratulates Partner CANbridge Pharmaceuticals on the Approval of Innovative Velaglucerase-beta for Injection (Gaurunning) for Gaucher Disease by China NMPA

WuXi Biologics Congratulates Partner CANbridge Pharmaceuticals on the Approval of Innovative Velaglucerase-beta for Injection (Gaurunning) for…

NRx Pharmaceuticals, Inc. (NRXP) Q1 2025 Earnings Call Transcript

NRx Pharmaceuticals, Inc. (NRXP) Q1 2025 Earnings Call Transcript #NRx #Pharmaceuticals #NRXP #Earnings #Call #Transcript

Lexicon Pharmaceuticals, Inc. 2025 Q1 – Results – Earnings Call Presentation

Lexicon Pharmaceuticals, Inc. 2025 Q1 – Results – Earnings Call Presentation #Lexicon #Pharmaceuticals #Results #Earnings #Call…

CNS Pharmaceuticals Soars Over 100% on $5 Million Offering: What’s Driving the Surge?

Buckle up, folks, because CNS Pharmaceuticals (NASDAQ: CNSP) is stealing the spotlight today, rocketing over 118%…

ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ

ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ#ANI #Pharmaceuticals #Participate…

Tarsus Pharmaceuticals: The "Get Big Fast" Approach Could Pay Off

Tarsus Pharmaceuticals: The "Get Big Fast" Approach Could Pay Off #Tarsus #Pharmaceuticals #quotGet #Big #Fastquot #Approach…

Aurinia Pharmaceuticals Inc. (AUPH) Q1 2025 Earnings Call Transcript

Aurinia Pharmaceuticals Inc. (AUPH) Q1 2025 Earnings Call Transcript #Aurinia #Pharmaceuticals #AUPH #Earnings #Call #Transcript

Rigel Pharmaceuticals: Q1 Earnings Showcase Growing Momentum

Rigel Pharmaceuticals: Q1 Earnings Showcase Growing Momentum #Rigel #Pharmaceuticals #Earnings #Showcase #Growing #Momentum

BioCryst Pharmaceuticals (BCRX) Surges on Q1 Earnings Beat: What Traders Need to Know

The stock market is a wild ride, and today, BioCryst Pharmaceuticals (BCRX) is stealing the spotlight…

Mirum Pharmaceuticals: A Respectable Liver, Rare Disease Franchise With Pipeline Opportunities

Mirum Pharmaceuticals: A Respectable Liver, Rare Disease Franchise With Pipeline Opportunities #Mirum #Pharmaceuticals #Respectable #Liver #Rare…

Agios Pharmaceuticals, Inc. 2025 Q1 – Results – Earnings Call Presentation (NASDAQ:AGIO)

Q1: 2025-05-01 Earnings Summary EPS of -$1.55 beats by $0.20  | Revenue of $8.73M (6.56% Y/Y) misses…

Tarsus Pharmaceuticals, Inc. (TARS) Q1 2025 Earnings Call Transcript

Tarsus Pharmaceuticals, Inc. (TARS) Q1 2025 Earnings Call Transcript #Tarsus #Pharmaceuticals #TARS #Earnings #Call #Transcript

Kiniksa Pharmaceuticals: A Biotech Stock on the Rise, But What’s Next?

As of this writing, Kiniksa Pharmaceuticals International Plc (KNSA) has seen a significant price movement in…

Singapore negotiating for US concessions on pharmaceuticals, chips

Singapore negotiating for US concessions on pharmaceuticals, chips#Singapore #negotiating #concessions #pharmaceuticals #chips

Aurinia Pharmaceuticals: Shareholder Pressure And Sales Growth

Aurinia Pharmaceuticals: Shareholder Pressure And Sales Growth #Aurinia #Pharmaceuticals #Shareholder #Pressure #Sales #Growth

Formosa Pharmaceuticals and Saval Corporation Announce Licensing Agreement for Clobetasol Propionate Ophthalmic Suspension for the Treatment of Post-Operative Inflammation and Pain

Formosa Pharmaceuticals and Saval Corporation Announce Licensing Agreement for Clobetasol Propionate Ophthalmic Suspension for the Treatment…